Cocaine and depressive disorders: When standard clinical diagnosis is insufficient

Statistics
Metrics and citations
Metadata
Show full item recordDate
2021Department
Neurociencias; PsicologíaSource
Alías-Ferri, M. García-Marchena, N, Mestre-Pinto, JI, Araos, P, Vergara-Moragues, E; Fonseca, F, González-Saiz, F, Rodríguez de Fonseca, F, Torrens, M & NEURODEP Group. (2021). Cocaine and depressive disorders: when standard clinical diagnosis is insufficient. Adicciones 33(3),193-199. doi: 10.20882/adicciones.1321Abstract
Background: Cocaine use is a growing global health problem and patients with cocaine use disorders (CUD) present several complications, including high rates of major depression. These subjects present two types of major depressive disorder (MDD): primary major depressive disorder (P-MDD) and cocaine-induced major depressive disorder (CI-MDD). To improve treatment, it is necessary to distinguish between both types. The aim of this study was to assess the differences in depressive symptomatology criteria (P-MDD vs CI-MDD) in CUD patients.
Methods: Secondary data analysis was carried out with a cross-sectional sample of 160 patients presenting CUD and MDD. Clinical assessment was performed using the Psychiatric Research Interview for Substance and Mental Disorders (PRISM). A differential diagnosis was obtained between P-MDD and CI-MDD.
Results: Men represented 80% of the sample, the mean age was 38.61 years, and 64.5% had elementary studies. CI-MDD diagnosis (61.3%) was more frequent than P-MDD (38.7%). There was a younger age of CUD onset in CI-MDD patients. In addition, 79.4% of the patients had another substance use disorder diagnosis. The criterion "Changes in weight or appetite" was more prevalent (57.1%) in P-MDD group.
Conclusions: We found differences in the criterion "Changes in weight or appetite". Further research is needed in this field to establish a differential diagnosis and thus provide better treatment for CUD patients.





